Exact Mass: 339.2116

Exact Mass Matches: 339.2116

Found 77 metabolites which its exact mass value is equals to given mass value 339.2116, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Propoxyphene

(3R)-4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-yl propanoate

C22H29NO2 (339.2198)


Propoxyphene is only found in individuals that have used or taken this drug. It is a narcotic analgesic structurally related to methadone. Only the dextro-isomer has an analgesic effect; the levo-isomer appears to exert an antitussive effect. [PubChem]Propoxyphene acts as a weak agonist at OP1, OP2, and OP3 opiate receptors within the central nervous system (CNS). Propoxyphene primarily affects OP3 receptors, which are coupled with G-protein receptors and function as modulators, both positive and negative, of synaptic transmission via G-proteins that activate effector proteins. Binding of the opiate stimulates the exchange of GTP for GDP on the G-protein complex. As the effector system is adenylate cyclase and cAMP located at the inner surface of the plasma membrane, opioids decrease intracellular cAMP by inhibiting adenylate cyclase. Subsequently, the release of nociceptive neurotransmitters such as substance P, GABA, dopamine, acetylcholine, and noradrenaline is inhibited. Opioids such as propoxyphene also inhibit the release of vasopressin, somatostatin, insulin, and glucagon. Opioids close N-type voltage-operated calcium channels (OP2-receptor agonist) and open calcium-dependent inwardly rectifying potassium channels (OP3 and OP1 receptor agonist). This results in hyperpolarization and reduced neuronal excitability. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics N - Nervous system > N02 - Analgesics > N02A - Opioids > N02AC - Diphenylpropylamine derivatives D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent D002491 - Central Nervous System Agents > D000700 - Analgesics

   

noracymethadol

Paracymethadol hydrochloride, (r*,r*)-(+-)-isomer

C22H29NO2 (339.2198)


noracymethadol is a metabolite of levomethadyl acetate. Levacetylmethadol, levomethadyl acetate (USAN), Orlaam (trade name) or levo-α-acetylmethadol (LAAM) is a synthetic opioid similar in structure to methadone. It has a long duration of action due to its active metabolites. (Wikipedia) D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D000700 - Analgesics

   
   

4-(3-(4-Benzylpiperidin-1-yl)-1-hydroxy-2-methylpropyl)phenol

4-(3-(4-Benzylpiperidin-1-yl)-1-hydroxy-2-methylpropyl)phenol

C22H29NO2 (339.2198)


   

Blonanserin C

1-[4-(4-fluorophenyl)-5H,6H,7H,8H,9H,10H-cycloocta[b]pyridin-2-yl]piperazine

C21H26FN3 (339.2111)


   

Bursin

2,6-Diamino-N-(1-{[(C-hydroxycarbonimidoyl)methyl]-C-hydroxycarbonimidoyl}-2-(1H-imidazol-5-yl)ethyl)hexanimidate

C14H25N7O3 (339.2019)


   

Bursopoietin

2,6-Diamino-N-(1-{[(C-hydroxycarbonimidoyl)methyl]-C-hydroxycarbonimidoyl}-2-(4H-imidazol-4-yl)ethyl)hexanimidate

C14H25N7O3 (339.2019)


   

l-Propoxyphene

4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-yl propanoate

C22H29NO2 (339.2198)


   

4-[(1R,2S)-3-(4-Benzylpiperidin-1-yl)-1-hydroxy-2-methylpropyl]phenol

4-[(1R,2S)-3-(4-Benzylpiperidin-1-yl)-1-hydroxy-2-methylpropyl]phenol

C22H29NO2 (339.2198)


   
   

(1-((Tetrahydro-2H-pyran-4-yl)methyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone

(1-((Tetrahydro-2H-pyran-4-yl)methyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone

C22H29NO2 (339.2198)


   
   
   

9-O-(erythro-2-hydroxy-2-methyl-3-tigloyloxy-butyryl)-(-)-trachelanthamidine|minalobine O

9-O-(erythro-2-hydroxy-2-methyl-3-tigloyloxy-butyryl)-(-)-trachelanthamidine|minalobine O

C18H29NO5 (339.2046)


   

1-[1]Naphthyl-cyclopentancarbonsaeure-(2-diaethylamino-aethylester)|1-[1]naphthyl-cyclopentanecarboxylic acid-(2-diethylamino-ethyl ester)

1-[1]Naphthyl-cyclopentancarbonsaeure-(2-diaethylamino-aethylester)|1-[1]naphthyl-cyclopentanecarboxylic acid-(2-diethylamino-ethyl ester)

C22H29NO2 (339.2198)


   

dioxo-3,18 conadiene-1,4

dioxo-3,18 conadiene-1,4

C22H29NO2 (339.2198)


   
   

oxo-3 hydroxy-18alpha conatriene-1,4,14

oxo-3 hydroxy-18alpha conatriene-1,4,14

C22H29NO2 (339.2198)


   

6beta-Isovaleryloxy-3alpha-tigloyloxy-tropanol-(7beta)

6beta-Isovaleryloxy-3alpha-tigloyloxy-tropanol-(7beta)

C18H29NO5 (339.2046)


   

2,4-Diphenylbutyric acid 2-(diethylamino)ethyl ester

2,4-Diphenylbutyric acid 2-(diethylamino)ethyl ester

C22H29NO2 (339.2198)


   

neorosmarinine

neorosmarinine

C18H29NO5 (339.2046)


   
   

(+)-7-epi-12-hydroxyjasmonoyl-L-isoleucine

(+)-7-epi-12-hydroxyjasmonoyl-L-isoleucine

C18H29NO5 (339.2046)


   
   

Propoxyphene

dextropropoxyphene

C22H29NO2 (339.2198)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics N - Nervous system > N02 - Analgesics > N02A - Opioids > N02AC - Diphenylpropylamine derivatives D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent D002491 - Central Nervous System Agents > D000700 - Analgesics CONFIDENCE standard compound; EAWAG_UCHEM_ID 3344

   

Vincadifformine

Vincadifformine

[C21H27N2O2]+ (339.2072)


Origin: Plant; SubCategory_DNP: Monoterpenoid indole alkaloids, Aspidosperma alkaloids, Indole alkaloids

   
   

N-(5Z,8Z,11Z,14Z-eicosatetrayoyl)-ethanolamine

N-(5Z,8Z,11Z,14Z-eicosatetrayoyl)-ethanolamine

C22H29NO2 (339.2198)


   

cis-5,8,11,14-eicosatetraynoyl ethanolamide

cis-5,8,11,14-eicosatetraynoyl ethanolamide

C22H29NO2 (339.2198)


   

NAE 20:8

cis-5,8,11,14-eicosatetraynoyl ethanolamide

C22H29NO2 (339.2198)


   

N-METHYLSARPAGINE METHOSALT

N-METHYLSARPAGINE METHOSALT

C21H27N2O2+ (339.2072)


   

levopropoxyphene

levopropoxyphene

C22H29NO2 (339.2198)


C78273 - Agent Affecting Respiratory System > C66917 - Antitussive Agent D019141 - Respiratory System Agents > D000996 - Antitussive Agents D002491 - Central Nervous System Agents

   
   

2-(Dicyclohexylphosphino)-1-phenyl-1H-pyrrole

2-(Dicyclohexylphosphino)-1-phenyl-1H-pyrrole

C22H30NP (339.2116)


   

4-[(1R,2S)-3-(4-Benzylpiperidin-1-yl)-1-hydroxy-2-methylpropyl]phenol

4-[(1R,2S)-3-(4-Benzylpiperidin-1-yl)-1-hydroxy-2-methylpropyl]phenol

C22H29NO2 (339.2198)


   

Propoxyphene, (R,R)-

Propoxyphene, (R,R)-

C22H29NO2 (339.2198)


   

2-[6-(2-Hydroxy-2-phenyl-ethyl)-1-methyl-2-piperidyl]-1-phenyl-ethanol

2-[6-(2-Hydroxy-2-phenyl-ethyl)-1-methyl-2-piperidyl]-1-phenyl-ethanol

C22H29NO2 (339.2198)


   

3alpha-hydroxy-3,5-dihydromonacolin L carboxylate

3alpha-hydroxy-3,5-dihydromonacolin L carboxylate

C19H31O5- (339.2171)


A hydroxy monocarboxylic acid anion that is the conjugate base of 3alpha-hydroxy-3,5-dihydromonacolin L acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

N-({(1R,2S)-2-[(2Z)-5-hydroxypent-2-en-1-yl]-3-oxocyclopentyl}acetyl)-L-isoleucine

N-({(1R,2S)-2-[(2Z)-5-hydroxypent-2-en-1-yl]-3-oxocyclopentyl}acetyl)-L-isoleucine

C18H29NO5 (339.2046)


   

[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-[3-(methylazaniumyl)propyl]azanium

[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-[3-(methylazaniumyl)propyl]azanium

C14H25N7O3+2 (339.2019)


   

methyl (1S,12R,19S)-12-ethyl-8-aza-16-azoniapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate

methyl (1S,12R,19S)-12-ethyl-8-aza-16-azoniapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate

C21H27N2O2+ (339.2072)


   

9-[6(S),9-diamino-5,6,7,8,9-pentadeoxy-beta-D-ribo-nonafuranosyl]-9H-purin-6-amine

9-[6(S),9-diamino-5,6,7,8,9-pentadeoxy-beta-D-ribo-nonafuranosyl]-9H-purin-6-amine

C14H25N7O3+2 (339.2019)


   

Noracymethadol, (-)-

Noracymethadol, (-)-

C22H29NO2 (339.2198)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics

   

Vincadifformine(1+)

Vincadifformine(1+)

C21H27N2O2+ (339.2072)


   

(+)-Vincadifformine(1+)

(+)-Vincadifformine(1+)

C21H27N2O2+ (339.2072)


An ammonium ion resulting from the protonation of the tertiary amino group of (+)-vincadifformine. The major species at pH 7.3.

   

Secodine(1+)

Secodine(1+)

C21H27N2O2+ (339.2072)


A tertiary ammonium ion that is the conjugate acid of secodine, obtained by protonation of the nitrogen atom of the tetrahydropyridine moiety. The major microspecies at pH 7.3.

   
   

1-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-propan-2-ylurea

1-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-propan-2-ylurea

C17H29N3O4 (339.2158)


   

1-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-propan-2-ylurea

1-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-propan-2-ylurea

C17H29N3O4 (339.2158)


   

1-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-propan-2-ylurea

1-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-propan-2-ylurea

C17H29N3O4 (339.2158)


   

1-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-propan-2-ylurea

1-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-propan-2-ylurea

C17H29N3O4 (339.2158)


   

1-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-propan-2-ylurea

1-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-propan-2-ylurea

C17H29N3O4 (339.2158)


   

1-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-propan-2-ylurea

1-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-propan-2-ylurea

C17H29N3O4 (339.2158)


   

1-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-propan-2-ylurea

1-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-propan-2-ylurea

C17H29N3O4 (339.2158)


   

N-({(1R)-2-[(2Z)-5-hydroxypent-2-en-1-yl]-3-oxocyclopentyl}acetyl)-L-isoleucine

N-({(1R)-2-[(2Z)-5-hydroxypent-2-en-1-yl]-3-oxocyclopentyl}acetyl)-L-isoleucine

C18H29NO5 (339.2046)


   

methyl (19S)-12-ethyl-16-aza-8-azoniapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,9-tetraene-10-carboxylate

methyl (19S)-12-ethyl-16-aza-8-azoniapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,9-tetraene-10-carboxylate

C21H27N2O2+ (339.2072)


   

NORACYMETHADOL

NORACYMETHADOL

C22H29NO2 (339.2198)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D000700 - Analgesics

   

l-Propoxyphene

l-Propoxyphene

C22H29NO2 (339.2198)


   

Nor-laam

L-alpha-Acetyl-N-normethadol

C22H29NO2 (339.2198)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics

   

(-)-vincadifformine(1+)

(-)-vincadifformine(1+)

C21H27N2O2 (339.2072)


An ammonium ion resulting from the protonation of the tertiary amino group of (-)-vincadifformine. The major species at pH 7.3.

   

(-)-coronaridine(1+)

(-)-coronaridine(1+)

C21H27N2O2 (339.2072)


An ammonium ion derivative resulting from the protonation of the tertiary amino group of (-)-coronaridine.

   

N-[(+)-12-hydroxy-7-isojasmonyl]isoleucine

N-[(+)-12-hydroxy-7-isojasmonyl]isoleucine

C18H29NO5 (339.2046)


An L-isoleucine derivative resulting from the formal condensation of the carboxy group of (+)-12-hydroxy-7-isojasmonic acid with the amino group of L-isoleucine.

   
   

(1s,3r,5r,6r,7s)-6-hydroxy-8-methyl-7-[(3-methylbutanoyl)oxy]-8-azabicyclo[3.2.1]octan-3-yl (2e)-2-methylbut-2-enoate

(1s,3r,5r,6r,7s)-6-hydroxy-8-methyl-7-[(3-methylbutanoyl)oxy]-8-azabicyclo[3.2.1]octan-3-yl (2e)-2-methylbut-2-enoate

C18H29NO5 (339.2046)


   

(2s,13s,15r,16r,19r,20r,21r)-21-hydroxy-1,11,19-trimethyl-18-oxa-1,11-diazahexacyclo[11.8.0.0²,¹⁶.0⁴,¹².0⁵,¹⁰.0¹⁵,²⁰]henicosa-4(12),5,7,9-tetraen-1-ium

(2s,13s,15r,16r,19r,20r,21r)-21-hydroxy-1,11,19-trimethyl-18-oxa-1,11-diazahexacyclo[11.8.0.0²,¹⁶.0⁴,¹².0⁵,¹⁰.0¹⁵,²⁰]henicosa-4(12),5,7,9-tetraen-1-ium

[C21H27N2O2]+ (339.2072)


   

2-{[(1r,2s,4r,8s)-2,6,7,7-tetramethyltricyclo[6.2.1.0¹,⁵]undec-5-en-4-yl]amino}benzoic acid

2-{[(1r,2s,4r,8s)-2,6,7,7-tetramethyltricyclo[6.2.1.0¹,⁵]undec-5-en-4-yl]amino}benzoic acid

C22H29NO2 (339.2198)


   

(1s)-2-[(2s,6s)-6-[(2s)-2-hydroxy-2-phenylethyl]-1-methylpiperidin-2-yl]-1-phenylethanol

(1s)-2-[(2s,6s)-6-[(2s)-2-hydroxy-2-phenylethyl]-1-methylpiperidin-2-yl]-1-phenylethanol

C22H29NO2 (339.2198)


   

(2r,3s)-4-[(1r,7as)-hexahydro-1h-pyrrolizin-1-ylmethoxy]-3-hydroxy-3-methyl-4-oxobutan-2-yl (2e)-2-methylbut-2-enoate

(2r,3s)-4-[(1r,7as)-hexahydro-1h-pyrrolizin-1-ylmethoxy]-3-hydroxy-3-methyl-4-oxobutan-2-yl (2e)-2-methylbut-2-enoate

C18H29NO5 (339.2046)


   

2-({2,6,7,7-tetramethyltricyclo[6.2.1.0¹,⁵]undec-5-en-4-yl}amino)benzoic acid

2-({2,6,7,7-tetramethyltricyclo[6.2.1.0¹,⁵]undec-5-en-4-yl}amino)benzoic acid

C22H29NO2 (339.2198)


   

(3r)-6-hydroxy-8-methyl-7-[(3-methylbutanoyl)oxy]-8-azabicyclo[3.2.1]octan-3-yl (2e)-2-methylbut-2-enoate

(3r)-6-hydroxy-8-methyl-7-[(3-methylbutanoyl)oxy]-8-azabicyclo[3.2.1]octan-3-yl (2e)-2-methylbut-2-enoate

C18H29NO5 (339.2046)


   

6-hydroxy-8-methyl-7-[(3-methylbutanoyl)oxy]-8-azabicyclo[3.2.1]octan-3-yl 2-methylbut-2-enoate

6-hydroxy-8-methyl-7-[(3-methylbutanoyl)oxy]-8-azabicyclo[3.2.1]octan-3-yl 2-methylbut-2-enoate

C18H29NO5 (339.2046)


   

(3s)-6-hydroxy-8-methyl-7-[(3-methylbutanoyl)oxy]-8-azabicyclo[3.2.1]octan-3-yl (2e)-2-methylbut-2-enoate

(3s)-6-hydroxy-8-methyl-7-[(3-methylbutanoyl)oxy]-8-azabicyclo[3.2.1]octan-3-yl (2e)-2-methylbut-2-enoate

C18H29NO5 (339.2046)


   

(1s)-2-[(2s,6r)-6-[(2r)-2-hydroxy-2-phenylethyl]-1-methylpiperidin-2-yl]-1-phenylethanol

(1s)-2-[(2s,6r)-6-[(2r)-2-hydroxy-2-phenylethyl]-1-methylpiperidin-2-yl]-1-phenylethanol

C22H29NO2 (339.2198)


   

4-(hexahydro-1h-pyrrolizin-1-ylmethoxy)-3-hydroxy-3-methyl-4-oxobutan-2-yl 2-methylbut-2-enoate

4-(hexahydro-1h-pyrrolizin-1-ylmethoxy)-3-hydroxy-3-methyl-4-oxobutan-2-yl 2-methylbut-2-enoate

C18H29NO5 (339.2046)


   

4-ethylidene-7,12-dihydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadecan-8-one

4-ethylidene-7,12-dihydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadecan-8-one

C18H29NO5 (339.2046)


   

(1r,4e,6r,7r,11s,12s,17r)-4-ethylidene-7,12-dihydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadecan-8-one

(1r,4e,6r,7r,11s,12s,17r)-4-ethylidene-7,12-dihydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadecan-8-one

C18H29NO5 (339.2046)